Startup profile

Axoft

Series ACambridge, Massachusetts, United States$55M raised

Open roles0
Total raised$55M
Team size11-50
Founded · Stage2021 · Series A

We pull jobs from sources most job seekers never check

Email icon

Get Real-Time Job Alerts For Free

Jobs updated every minute. Get notified for free when new roles matching your interests go live.

No categories available

About the company

What they build and who they serve.

Axoft is a Cambridge, Massachusetts neurotechnology company developing implantable brain-computer interfaces (iBCIs) built on its proprietary Fleuron material, which is engineered to be roughly 10,000x softer than the polyimide used in conventional neural implants. The company was co-founded in 2021 by Paul Le Floch, Tianyang Ye, and Harvard professor Jia Liu, and has implanted its devices in 11 patients across early clinical studies aimed at improving prognosis and communication for people with neurological disorders. Axoft also commercializes Fleuron for biomedical applications under an exclusive licensing agreement with Stanford University.

Team & contacts

Key people at the company—reach out on LinkedIn or email.

Why it matters

Signals from funding, traction, and product direction.

  • Round was oversubscribed and brings Axoft total funding to more than $60M since its 2022 seed round
  • Axoft has implanted its iBCIs in 11 patients to date worldwide, including a first-in-human study with The Panama Clinic and high-fidelity decoding trials in China
  • Proprietary Fleuron material is up to 10,000x softer than the polyimide used in existing brain implants and is exclusively licensed from Stanford University; published in Nature in December 2023 and June 2025
  • Recent traction includes a joint development agreement with Kayaku Advanced Materials, a Massachusetts Manufacturing Innovation Initiative grant, and a new subsidiary opened in Grenoble, France

Funding history

Rounds and investors over time, newest first.

  1. Series A

    $55M
    Gaorong VenturesAlumni VenturesHillhouse Investment Management, Ltd.C.P. Group Innovation · LeadStanford President's Venture Fund

In the news

Press, announcements, and coverage about this company.

Investors

Gaorong VenturesAlumni VenturesHillhouse Investment Management, Ltd.C.P. Group InnovationStanford President's Venture Fund

Focus areas

BiotechnologyClinical TrialsHealthtechMedical DevicesNeuroscience
Email alerts

Don’t get beat to tomorrow’s openings

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.

👉 Get free daily job posts